Search by Drug Name or NDC
NDC 60687-0669-01 Methimazole 5 mg/1 Details
Methimazole 5 mg/1
Methimazole is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is METHIMAZOLE.
MedlinePlus Drug Summary
Methimazole is used to treat hyperthyroidism, a condition that occurs when the thyroid gland produces too much thyroid hormone. It is also taken before thyroid surgery or radioactive iodine therapy. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 60687-0669-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Methimazole
Product Information
| NDC | 60687-0669 |
|---|---|
| Product ID | 60687-669_f4224f83-f7e0-063a-e053-2a95a90afff0 |
| Associated GPIs | |
| GCN Sequence Number | 006675 |
| GCN Sequence Number Description | methimazole TABLET 5 MG ORAL |
| HIC3 | P3L |
| HIC3 Description | ANTITHYROID PREPARATIONS |
| GCN | 26401 |
| HICL Sequence Number | 002855 |
| HICL Sequence Number Description | METHIMAZOLE |
| Brand/Generic | Generic |
| Proprietary Name | Methimazole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | methimazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | METHIMAZOLE |
| Labeler Name | American Health Packaging |
| Pharmaceutical Class | Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040350 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60687-0669-01 (60687066901)
| NDC Package Code | 60687-669-01 |
|---|---|
| Billing NDC | 60687066901 |
| Package | 100 BLISTER PACK in 1 CARTON (60687-669-01) / 1 TABLET in 1 BLISTER PACK (60687-669-11) |
| Marketing Start Date | 2022-08-20 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.09303 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | METHIMAZOLE 5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis